MAZE Maze Therapeutics, Inc. logo

MAZE Maze Therapeutics, Inc.

Healthcare
$26.35+2.21%ClosedMarket Cap: $1.46B

As of 2026-05-26

Insider Statistics (Q2 2026)

Acquisitions

5

Dispositions

12

Buy/Sell Ratio

0.42

Net Shares

-32,422

Shares Acquired

39,305

Shares Disposed

71,727

Total Bought ($)

$0.00

Total Sold ($)

$6.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Mon May 18Coloma Jason Vdirector, officer: Chief Executive OfficerSell1,822$26.00381,073
Mon May 18Coloma Jason Vdirector, officer: Chief Executive OfficerSell116$26.0031,001
Mon May 18Bernstein Haroldofficer: President, R&D & CMOSell15,000$26.220
Mon May 18Bernstein Haroldofficer: President, R&D & CMOSell15,000$10.42222,407
Wed May 06HOMCY CHARLES JdirectorSell7,422$0.0031,113
Wed May 06Dandekar Atulofficer: CSBOSell8,320$10.4220,204
Wed May 06Dandekar Atulofficer: CSBOSell5,985$10.4227,725
Fri May 01Dandekar Atulofficer: CSBOSell7,500$25.3710,503
Fri May 01Dandekar Atulofficer: CSBOSell7,500$10.4244,143
Thu Apr 02Bernstein Haroldofficer: President, R&D & CMOSell11,352$29.243,648
Thu Apr 02Bernstein Haroldofficer: President, R&D & CMOSell3,348$30.06300
Thu Apr 02Bernstein Haroldofficer: President, R&D & CMOSell300$31.070
Thu Apr 02Bernstein Haroldofficer: President, R&D & CMOSell15,000$10.42237,407
Thu Apr 02Bachrodt Amyofficer: SVP, FinanceSell2,200$29.3213,265
Thu Apr 02Bachrodt Amyofficer: SVP, FinanceSell300$30.3412,965